SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5.26 |
Enterprise Value ($M) | 3.77 |
Book Value ($M) | 1.66 |
Book Value / Share | 0.20 |
Price / Book | 3.16 |
NCAV ($M) | -0.32 |
NCAV / Share | -0.04 |
Price / NCAV | -16.20 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -13.64 |
Return on Assets (ROA) | -2.13 |
Return on Equity (ROE) | -3.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.86 |
Current Ratio | 0.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.92 |
Assets | 3.91 |
Liabilities | 2.24 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Forsakringsaktiebolaget Avanza Pension | |||
13G/A | Otsuka Masaya | 0.00 | -100.00 | |
13G/A | CVI Investments, Inc. | 4.90 | -10.86 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
72,540 | 513,034 | 14.14 | |
55,854 | 213,030 | 26.22 | |
25,928 | 262,182 | 9.89 | |
25,067 | 163,524 | 15.33 | |
(click for more detail) |
Similar Companies | |
---|---|
GLTO – Galecto, Inc. | GLYC – GlycoMimetics, Inc. |
GNLX – Genelux Corporation | GOVX – GeoVax Labs, Inc. |
GRCE – Grace Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io